Marketed in 37 countries across the Americas, Europe, and the Asia-Pacific, Acular is a globally distributed brand of ketorolac, classified within the nonsteroidal anti-inflammatory and ophthalmologic agent categories. The footprint puts the brand in front of travellers and expatriates in markets as varied as Brazil, Germany, India, Australia, and Canada, often in contexts where short-term analgesia or ophthalmic anti-inflammatory therapy is needed.
Ketorolac is used in the management of pain, including post-surgical pain, toothache, and colic-type pain, and within the broader analgesic, antipyretic, and anti-inflammatory therapeutic areas. The structured indication block further down this page lists the registered uses across the markets where Acular is sold; these can vary from country to country, since the same active ingredient is sometimes authorised for ophthalmic use, sometimes for systemic short-term analgesia, and sometimes both, depending on the local regulator.
Because Acular is broadly distributed, travellers carrying a prescription from home will often find ketorolac available in their destination country — though not always under the Acular name. The same active ingredient circulates internationally under several brand names, and packaging, indications, and prescription pathways differ between regulatory regimes. A pharmacist in the destination market is well placed to confirm whether a locally stocked ketorolac product corresponds to what the patient has been using.
Other medications in the broader nonsteroidal anti-inflammatory class are sold in essentially every regulated market in the world, although molecules within the class are not freely interchangeable and have meaningfully different clinical profiles. Anyone taking Acular, considering an equivalent abroad, or weighing a substitution should treat that decision as a clinical one and bring it to a healthcare provider rather than resolve it at the counter.
Acular is used in the management of pain — including post-surgical pain, toothache, and colic-type pain — and falls within the analgesic, antipyretic, and anti-inflammatory therapeutic categories, with ketorolac also recognised as an ophthalmologic agent in several markets. The exact registered indications differ between countries, and the structured indication section below this introduction lists the uses authorised in each market where Acular is sold.
Acular contains ketorolac, a nonsteroidal anti-inflammatory molecule that is also classified as an ophthalmologic agent in formulations intended for ocular use. Ketorolac is the same active ingredient regardless of the brand name on the box, and it circulates internationally under several commercial names, particularly in markets where multiple manufacturers produce ketorolac-containing products in parallel.
Acular is registered in 37 countries, spanning North and South America, Europe, and parts of Asia and Oceania. Examples include Brazil, Canada, Germany, India, China, Australia, and Denmark. If your country is not represented in the list shown on this page, a local pharmacist can usually confirm whether ketorolac is available in that market under a different brand name or as a generic.
Ketorolac is sold under several brand names worldwide, both as ophthalmic preparations and as systemic short-term analgesics, depending on the regulator. The broader nonsteroidal anti-inflammatory class is also well represented internationally under many other molecules, although they are not freely interchangeable. To identify a local ketorolac-containing product, search the active ingredient on Pill2Trip or ask a pharmacist in your country.
Yes. Ketorolac is a prescription medication in most jurisdictions, and its short-term analgesic and ophthalmic uses are calibrated to individual circumstances and concurrent medications. Prescription requirements, available formulations, and registered indications differ between countries, which matters particularly for travellers and people relocating. Any decision to start, continue, switch, or substitute Acular should be made together with a healthcare provider familiar with the patient's history.
